Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Crl
  6. /
  7. RB Health (US) LLC
CRL
•RB Health (US) LLC

RB Health (US) LLC – FDA CRL

Record Details

The U.S. Food and Drug Administration (FDA) issued a Complete Response Letter on July 26, 2024, to RB Health (US) LLC regarding their New Drug Application (NDA 217338) for an extended-release tablet containing naproxen sodium, dextromethorphan hydrobromide, and guaifenesin. The primary issue identified was insufficient evidence to support the proposed 12-hour duration of action and dosing regimen for the combination product. While bioequivalence to approved components like Aleve was demonstrated, the FDA determined this was inadequate to justify a fixed 12-hour dosing interval, noting Aleve's 8-12 hour instructions. Additionally, supporting scientific literature was deemed insufficient due to varied formulations, and an indirect pharmacokinetic bridge relying on FDA reviews was considered an inappropriate regulatory source, as per 21 CFR 314.430(e)(2). The FDA expressed concerns about potential waning analgesic effects. To address these deficiencies, RB Health must either provide new clinical efficacy data for a 12-hour duration in a relevant patient population or conduct a relative bioavailability study to bridge to an existing product. Furthermore, a comprehensive safety update, as described in 21 CFR 314.50(d)(5)(vi)(b), is required upon resubmission. RB Health has one year to respond, and the submission must be clearly marked as a 'RESUBMISSION'.

Company
RB Health (US) LLC
Product type
NDA (New Drug Application)
Office
Center for Drug Evaluation and Research
Person
  • Ebru Unver Kulak
View Company Profile

ID · b42ad095-70d2-4eda-8f84-d1d979f64a7a

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore RB Health (US) LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.